Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H16N4.2C2H6O4S |
Molecular Weight | 516.588 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCS(O)(=O)=O.OCCS(O)(=O)=O.NC(=N)C1=CC=C(C=C1)\C=C\C2=CC=C(C=C2)C(N)=N
InChI
InChIKey=DXBSRDIXJYTKNV-SEPHDYHBSA-N
InChI=1S/C16H16N4.2C2H6O4S/c17-15(18)13-7-3-11(4-8-13)1-2-12-5-9-14(10-6-12)16(19)20;2*3-1-2-7(4,5)6/h1-10H,(H3,17,18)(H3,19,20);2*3H,1-2H2,(H,4,5,6)/b2-1+;;
Molecular Formula | C16H16N4 |
Molecular Weight | 264.325 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Molecular Formula | C2H6O4S |
Molecular Weight | 126.132 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Stilbamidine Isethionate is a salt of Stilbenedicarboxamidine and Hydroxyethanesulfonic acid produced by The Wm. S. Merrell Company and was tested clinically for the treatment of tropical trypano- somiasis and leishmaniasis. It was also reportedly used for tic douloureux. This drug was replaced by Hydroxystilbamidinr isethionate ampuls (Merrell) because this derivative is less toxic and is equally effective in the treatment of the systemic fungus infections, blastomycosis, leishmaniasis, and Indian kala-azar
Originator
Approval Year
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
40 μg/mL |
8 mg single, oral dose: 8 mg route of administration: Oral experiment type: SINGLE co-administered: |
STILBAMIDINE serum | Mus musculus population: HEALTHY age: ADULT sex: UNKNOWN food status: FASTED |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
15 μg × h/mL |
8 mg single, oral dose: 8 mg route of administration: Oral experiment type: SINGLE co-administered: |
STILBAMIDINE serum | Mus musculus population: HEALTHY age: ADULT sex: UNKNOWN food status: FASTED |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
45 min |
8 mg single, oral dose: 8 mg route of administration: Oral experiment type: SINGLE co-administered: |
STILBAMIDINE serum | Mus musculus population: HEALTHY age: ADULT sex: UNKNOWN food status: FASTED |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:01:08 GMT 2023
by
admin
on
Fri Dec 15 16:01:08 GMT 2023
|
Record UNII |
Y56ICS757E
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
140-59-0
Created by
admin on Fri Dec 15 16:01:08 GMT 2023 , Edited by admin on Fri Dec 15 16:01:08 GMT 2023
|
PRIMARY | |||
|
SUB10650MIG
Created by
admin on Fri Dec 15 16:01:08 GMT 2023 , Edited by admin on Fri Dec 15 16:01:08 GMT 2023
|
PRIMARY | |||
|
100000083481
Created by
admin on Fri Dec 15 16:01:08 GMT 2023 , Edited by admin on Fri Dec 15 16:01:08 GMT 2023
|
PRIMARY | |||
|
41802
Created by
admin on Fri Dec 15 16:01:08 GMT 2023 , Edited by admin on Fri Dec 15 16:01:08 GMT 2023
|
PRIMARY | |||
|
m10215
Created by
admin on Fri Dec 15 16:01:08 GMT 2023 , Edited by admin on Fri Dec 15 16:01:08 GMT 2023
|
PRIMARY | Merck Index | ||
|
97
Created by
admin on Fri Dec 15 16:01:08 GMT 2023 , Edited by admin on Fri Dec 15 16:01:08 GMT 2023
|
PRIMARY | |||
|
CHEMBL142304
Created by
admin on Fri Dec 15 16:01:08 GMT 2023 , Edited by admin on Fri Dec 15 16:01:08 GMT 2023
|
PRIMARY | |||
|
C152431
Created by
admin on Fri Dec 15 16:01:08 GMT 2023 , Edited by admin on Fri Dec 15 16:01:08 GMT 2023
|
PRIMARY | |||
|
Y56ICS757E
Created by
admin on Fri Dec 15 16:01:08 GMT 2023 , Edited by admin on Fri Dec 15 16:01:08 GMT 2023
|
PRIMARY | |||
|
6433163
Created by
admin on Fri Dec 15 16:01:08 GMT 2023 , Edited by admin on Fri Dec 15 16:01:08 GMT 2023
|
PRIMARY | |||
|
C042560
Created by
admin on Fri Dec 15 16:01:08 GMT 2023 , Edited by admin on Fri Dec 15 16:01:08 GMT 2023
|
PRIMARY | |||
|
205-421-5
Created by
admin on Fri Dec 15 16:01:08 GMT 2023 , Edited by admin on Fri Dec 15 16:01:08 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |